Stockreport

Addex Therapeutics Ltd (ADXN) Q2 2025 Earnings Call Highlights: Strategic Advances Amid ... [Yahoo! Finance]

Addex Therapeutics Ltd - American Depositary Shares  (ADXN) 
PDF Income: Decreased by CHF0.1 million in Q2 2025 compared to 2024, amounting to CHF0.1 million. R&D Expenses: CHF0.2 million in Q2 2025, decreased by CHF0.1 million com [Read more]